These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 36115414)

  • 41. Astragaloside IV ameliorates high glucose‑induced renal tubular epithelial‑mesenchymal transition by blocking mTORC1/p70S6K signaling in HK‑2 cells.
    Chen X; Yang Y; Liu C; Chen Z; Wang D
    Int J Mol Med; 2019 Feb; 43(2):709-716. PubMed ID: 30483732
    [TBL] [Abstract][Full Text] [Related]  

  • 42. miR-21 overexpression enhances TGF-β1-induced epithelial-to-mesenchymal transition by target smad7 and aggravates renal damage in diabetic nephropathy.
    Wang JY; Gao YB; Zhang N; Zou DW; Wang P; Zhu ZY; Li JY; Zhou SN; Wang SC; Wang YY; Yang JK
    Mol Cell Endocrinol; 2014 Jul; 392(1-2):163-72. PubMed ID: 24887517
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Enhanced expression of two discrete isoforms of matrix metalloproteinase-2 in experimental and human diabetic nephropathy.
    Kim SS; Shin N; Bae SS; Lee MY; Rhee H; Kim IY; Seong EY; Lee DW; Lee SB; Kwak IS; Lovett DH; Song SH
    PLoS One; 2017; 12(2):e0171625. PubMed ID: 28178341
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Connexin 43 prevents the progression of diabetic renal tubulointerstitial fibrosis by regulating the SIRT1-HIF-1α signaling pathway.
    Sun X; Huang K; Haiming X; Lin Z; Yang Y; Zhang M; Liu P; Huang H
    Clin Sci (Lond); 2020 Jul; 134(13):1573-1592. PubMed ID: 32558900
    [TBL] [Abstract][Full Text] [Related]  

  • 45. miR-30e targets GLIPR-2 to modulate diabetic nephropathy:
    Zhao D; Jia J; Shao H
    J Mol Endocrinol; 2017 Aug; 59(2):181-190. PubMed ID: 28733476
    [TBL] [Abstract][Full Text] [Related]  

  • 46. FGF2 antagonizes aberrant TGFβ regulation of tropomyosin: role for posterior capsule opacity.
    Kubo E; Shibata S; Shibata T; Kiyokawa E; Sasaki H; Singh DP
    J Cell Mol Med; 2017 May; 21(5):916-928. PubMed ID: 27976512
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Low-molecular-weight fibroblast growth factor 2 attenuates hepatic fibrosis by epigenetic down-regulation of Delta-like1.
    Pan RL; Xiang LX; Wang P; Liu XY; Nie L; Huang W; Shao JZ
    Hepatology; 2015 May; 61(5):1708-20. PubMed ID: 25501710
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nuclear fibroblast growth factor 2 (FGF2) isoforms inhibit bone marrow stromal cell mineralization through FGF23/FGFR/MAPK in vitro.
    Xiao L; Esliger A; Hurley MM
    J Bone Miner Res; 2013 Jan; 28(1):35-45. PubMed ID: 22836867
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Urotensin II Induces ER Stress and EMT and Increase Extracellular Matrix Production in Renal Tubular Epithelial Cell in Early Diabetic Mice.
    Pang XX; Bai Q; Wu F; Chen GJ; Zhang AH; Tang CS
    Kidney Blood Press Res; 2016; 41(4):434-49. PubMed ID: 27467277
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The coordinated roles of miR-26a and miR-30c in regulating TGFβ1-induced epithelial-to-mesenchymal transition in diabetic nephropathy.
    Zheng Z; Guan M; Jia Y; Wang D; Pang R; Lv F; Xiao Z; Wang L; Zhang H; Xue Y
    Sci Rep; 2016 Nov; 6():37492. PubMed ID: 27874055
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Quercetin inhibits the mTORC1/p70S6K signaling-mediated renal tubular epithelial-mesenchymal transition and renal fibrosis in diabetic nephropathy.
    Lu Q; Ji XJ; Zhou YX; Yao XQ; Liu YQ; Zhang F; Yin XX
    Pharmacol Res; 2015 Sep; 99():237-47. PubMed ID: 26151815
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Alternative polyadenylation writer CSTF2 forms a positive loop with FGF2 to promote tubular epithelial-mesenchymal transition and renal fibrosis.
    Tan Y; Zheng T; Zhang R; Chen S; Cheng Q; Zhang J; Wang R; Chen M; Na N
    Biochim Biophys Acta Mol Basis Dis; 2022 Dec; 1868(12):166541. PubMed ID: 36113752
    [TBL] [Abstract][Full Text] [Related]  

  • 53. BMP-7 inhibits renal fibrosis in diabetic nephropathy via miR-21 downregulation.
    Liu L; Wang Y; Yan R; Liang L; Zhou X; Liu H; Zhang X; Mao Y; Peng W; Xiao Y; Zhang F; Liu L; Shi M; Guo B
    Life Sci; 2019 Dec; 238():116957. PubMed ID: 31655195
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fibroblast growth factor 2 accelerates the epithelial-mesenchymal transition in keratinocytes during wound healing process.
    Koike Y; Yozaki M; Utani A; Murota H
    Sci Rep; 2020 Oct; 10(1):18545. PubMed ID: 33122782
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Zinc Attenuates Tubulointerstitial Fibrosis in Diabetic Nephropathy Via Inhibition of HIF Through PI-3K Signaling.
    Zhang X; Liang D; Fan J; Lian X; Zhao Y; Wang X; Chi ZH; Zhang P
    Biol Trace Elem Res; 2016 Oct; 173(2):372-83. PubMed ID: 26956696
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Lipid accumulation is ahead of epithelial-to-mesenchymal transition and therapeutic intervention by acetyl-CoA carboxylase 2 silence in diabetic nephropathy.
    Xu Y; Huang J; Xin W; Chen L; Zhao X; Lv Z; Liu Y; Wan Q
    Metabolism; 2014 May; 63(5):716-26. PubMed ID: 24650564
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [EZH2 promotes development and progression of diabetic nephropathy].
    Ruan Y; Zhang Y; Zhao J; Li X; Zhou X; Xie Y; Guo B; Zhang F
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2020 Mar; 36(3):212-219. PubMed ID: 32389168
    [TBL] [Abstract][Full Text] [Related]  

  • 58. miR302a-3p May Modulate Renal Epithelial-Mesenchymal Transition in Diabetic Kidney Disease by Targeting ZEB1.
    Tang WB; Zheng L; Yan R; Yang J; Ning J; Peng L; Zhou Q; Chen L
    Nephron; 2018; 138(3):231-242. PubMed ID: 29227974
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Huangkui capsule alleviates renal tubular epithelial-mesenchymal transition in diabetic nephropathy via inhibiting NLRP3 inflammasome activation and TLR4/NF-κB signaling.
    Han W; Ma Q; Liu Y; Wu W; Tu Y; Huang L; Long Y; Wang W; Yee H; Wan Z; Tang R; Tang H; Wan Y
    Phytomedicine; 2019 Apr; 57():203-214. PubMed ID: 30785016
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Phosphoproteomic analysis identifies phospho-Threonine-17 site of phospholamban important in low molecular weight isoform of fibroblast growth factor 2-induced protection against post-ischemic cardiac dysfunction.
    Manning JR; Wijeratne AB; Oloizia BB; Zhang Y; Greis KD; Schultz JEJ
    J Mol Cell Cardiol; 2020 Nov; 148():1-14. PubMed ID: 32853649
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.